Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Repeated P. falciparum CHMI
NCT03906474Completed
- Sponsor
- University of Oxford
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by University of Oxford. Primary endpoints: Safety of primary, secondary and tertiary blood-stage controlled human Plasmodium falciparum malaria infection at 3 months and Effect of prior blood-stage CHMI on parasite multiplication rate at 3 months. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03906474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03906474.